Bausch & Lomb CorpBLCO
時価総額
$53.3億
PER
眼科医療製品の大手。コンタクトレンズ、処方薬、手術器具を展開。23年6月のXIIDRA買収（17.5億ドル）と24年7月のTrukera買収（約2400万ドル）を実施。世界約100カ国で展開、製造拠点は23拠点10カ国。
| 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Product sales | 3,746 | 4,131 | 4,774 |
| Other revenues | 22 | 15 | 17 |
| Total revenues | 3,768 | 4,146 | 4,791 |
| Product sales | 1,511 | 1,640 | 1,868 |
| Other revenues | 8 | 2 | 4 |
| Selling, General and Administrative Expense | 1,478 | 1,736 | 2,082 |
| Research and development (Note 3) | 307 | 324 | 343 |
| Amortization of intangible assets | 244 | 240 | 288 |
| Other expense, net | -13 | -74 | -44 |
| Total expenses | 3,561 | 4,016 | 4,629 |
| Operating income | 207 | 130 | 162 |
| Interest income | 6 | 15 | 15 |
| Interest expense (Note 3) | 146 | 283 | 399 |
| Foreign exchange and other | 6 | -28 | -12 |
| (Loss) income before provision for income taxes | 73 | -166 | -234 |
| Provision for income taxes | 58 | 82 | 71 |
| Net (loss) income | 15 | -248 | -305 |
| Net income attributable to noncontrolling interest | 9 | 12 | 12 |
| Net (loss) income attributable to Bausch + Lomb Corporation | 15 | -248 | -305 |
| Earnings Per Share, Basic | 0.02 | -0.74 | -0.9 |
| Earnings Per Share, Diluted | 0.02 | -0.74 | -0.9 |